InMode Ltd. (INMD)
$14.28-0.21%Close
SELLBEAR · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $821M
- Beta
- 2.03
- P/E (TTM)
- 11.42
- Short % float
- 4.55%
- Days to cover
- 5.0
- SI change
- -4.5%
- 1W
- +1.93%
- 1M
- -3.97%
- vs SPY 1W
- +2.07%
- vs SPY 1M
- -6.47%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 36
- VALUE
- 33
- GROWTH
- 77
- GARP
- 43
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC7.1%
REV YoY-
ROE11.8%
EPS YoY-
ROA10.8%
GROSS77
OP18
NET21
[VALUATION]
P/E TTM11.42
P/E FWD11.78
SECTOR PE20.48
INDUSTRY PE22.31
P/B1.34
P/FCF-
EV/EBITDA5.11
EV/EBIT-
PEG2.02
FCF YIELD-
RISK
INT COV-
D/E0.71
ALTMAN Z-
CURR RATIO8.18
ND/EBITDA-
BETA2.03
Company news
FAQ
- What is LOPJLB’s current signal on INMD?
- LOPJLB’s latest quantitative signal on InMode Ltd. (INMD) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is INMD in?
- InMode Ltd. (INMD) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does InMode Ltd. (INMD) do?
- InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subde…